Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

An intranasal influenza virus-vectored vaccine prevents SARS-CoV-2 replication in respiratory tissues of mice and hamsters
Shaofeng Deng, Ying Liu, Rachel Chun-Yee Tam, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 25

Showing 25 citing articles:

Broad protection against clade 1 sarbecoviruses after a single immunization with cocktail spike-protein-nanoparticle vaccine
Peter Halfmann, Kathryn Loeffler, Augustine Duffy, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 9
Mucosal vaccines for viral diseases: Status and prospects
Bingjie Ma, Mengxiao Tao, Zhili Li, et al.
Virology (2024) Vol. 593, pp. 110026-110026
Closed Access | Times Cited: 6
Novel vaccine strategies to induce respiratory mucosal immunity: advances and implications
Ming Zhou, Haihua Xiao, Xinyi Yang, et al.
MedComm (2025) Vol. 6, Iss. 2
Open Access
A truncated pre-F protein mRNA vaccine elicits an enhanced immune response and protection against respiratory syncytial virus
Min Lin, Yifan Yin, Xiaomeng Zhao, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
OVX033, a nucleocapsid-based vaccine candidate, provides broad-spectrum protection against SARS-CoV-2 variants in a hamster challenge model
Charlotte Primard, Élodie Monchâtre-Leroy, Judith del Campo, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 19
An intranasal influenza virus vector vaccine protects against Helicobacter pylori in mice
Longyu Nie, Yu Huang, Zhikui Cheng, et al.
Journal of Virology (2024) Vol. 98, Iss. 3
Open Access | Times Cited: 3
The role of engineered materials in mucosal vaccination strategies
Behnaz Eshaghi, Alex Schudel, Ilin Sadeghi, et al.
Nature Reviews Materials (2023) Vol. 9, Iss. 1, pp. 29-45
Closed Access | Times Cited: 8
Intranasal B5 promotes mucosal defence against Actinobacillus pleuropneumoniae via ameliorating early immunosuppression
Jingsheng Huang, Weichao Kang, Dandan Yi, et al.
Virulence (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 2
The recent advancements in protein nanoparticles for immunotherapy
Miaomiao Xu, Siyuan Wei, Lifan Duan, et al.
Nanoscale (2024) Vol. 16, Iss. 25, pp. 11825-11848
Closed Access | Times Cited: 2
Intranasal Boosting with Spike Fc-RBD of Wild-Type SARS-CoV-2 Induces Neutralizing Antibodies against Omicron Subvariants and Reduces Viral Load in the Nasal Turbinate of Mice
Jian‐Piao Cai, Cuiting Luo, Kun Wang, et al.
Viruses (2023) Vol. 15, Iss. 3, pp. 687-687
Open Access | Times Cited: 5
Bioprocessing and the Production of Antiviral Biologics in the Prevention and Treatment of Viral Infectious Disease
Elaine Meade, Neil J. Rowan, Mary Garvey
Vaccines (2023) Vol. 11, Iss. 5, pp. 992-992
Open Access | Times Cited: 5
Influenza virus strains expressing SARS-CoV-2 receptor binding domain protein confer immunity in K18-hACE2 mice
Nathaniel A. Rader, Katherine S. Lee, Andrea N. Loes, et al.
Vaccine X (2024) Vol. 20, pp. 100543-100543
Open Access | Times Cited: 1
Harnessing the potential of the NALT and BALT as targets for immunomodulation using engineering strategies to enhance mucosal uptake
Madison L. Seefeld, Erin L. Templeton, Justin M. Lehtinen, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Novel 3D integrated microfluidic device: Design, construction, and application to the preparation of liposomes for vaccine delivery
Xueliang Xiu, Shichao Ma, Zhiyong Li, et al.
Journal of Drug Delivery Science and Technology (2023) Vol. 91, pp. 105191-105191
Closed Access | Times Cited: 3
Analysis of the protective efficacy of approved COVID-19 vaccines against Omicron variants and the prospects for universal vaccines
Keda Chen, Ling Zhang, Zhongbiao Fang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 3
Assessment of Single‐Cycle M‐Protein Mutated Vesicular Stomatitis Virus as a Safe and Immunogenic Mucosal Vaccine Platform for SARS‐CoV‐2 Immunogen Delivery
En Zhang, Yong Ke, Ran Wei, et al.
Advanced Science (2024)
Open Access
Pandemic research: the need for a paradigm shift
Lin‐Fa Wang, Sharon R. Lewin, Nanshan Zhong, et al.
The Lancet Microbe (2024), pp. 101048-101048
Closed Access
Challenges and strategies in the soluble expression of CTA1-(S14P5)4-DD and CTA1-(S21P2)4-DD fusion proteins as candidates for COVID-19 intranasal vaccines
Simson Tarigan, Gita Sekarmila, Apas, et al.
PLoS ONE (2024) Vol. 19, Iss. 12, pp. e0306153-e0306153
Open Access
Mucosal Immunization with an Influenza Vector Carrying SARS-CoV-2 N Protein Protects Naïve Mice and Prevents Disease Enhancement in Seropositive Th2-Prone Mice
Maria V. Sergeeva, Kirill Vasilev, Ekaterina A. Romanovskaya-Romanko, et al.
Vaccines (2024) Vol. 13, Iss. 1, pp. 15-15
Open Access
The Papain-like Protease Domain of Severe Acute Respiratory Syndrome Coronavirus 2 Conjugated with Human Beta-Defensin 2 and Co1 Induces Mucosal and Systemic Immune Responses against the Virus
Byeol-Hee Cho, Ju Kim, Yong‐Suk Jang
Vaccines (2024) Vol. 12, Iss. 4, pp. 441-441
Open Access
Optimization of Soluble Expression of CTA1-(S14P5)4-DD and CTA1-(S21P2)4-DD Fusion Proteins as Candidates for COVID-19 Intranasal Vaccines
Simson Tarigan, Sumarningsih Sumarningsih, Gita Sekarmila, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Immunogenicity of intranasal vaccine based on SARS-CoV-2 spike protein during primary and booster immunizations in mice
Huijie Yang, Ying Xie, Shuyan Li, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access
A chimeric mRNA vaccine of S-RBD with HA conferring broad protection against influenza and COVID-19 variants
Tianjiao Hao, Yulei Li, Peipei Liu, et al.
PLoS Pathogens (2024) Vol. 20, Iss. 9, pp. e1012508-e1012508
Open Access
Intranasal vaccination of Syrian Hamsters with ChAd-SARS-CoV-2-S disrupts airborne transmission cycles of SARS-CoV-2
Adrianus C. M. Boon, Tamarand L. Darling, Houda Harastani, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 1
Clade 2.3.4.4 H5 chimeric cold-adapted attenuated influenza vaccines induced cross-reactive protection in mice and ferrets
Weiyang Sun, Jiaqi Xu, Zhenfei Wang, et al.
Journal of Virology (2023) Vol. 97, Iss. 11
Open Access | Times Cited: 1
Page 1

Scroll to top